| Literature DB >> 26824864 |
Chitrita DebRoy1, Pina M Fratamico2, Xianghe Yan2, GianMarco Baranzoni2, Yanhong Liu2, David S Needleman2, Robert Tebbs3, Catherine D O'Connell3, Adam Allred3, Michelle Swimley3, Michael Mwangi1, Vivek Kapur1, Juan A Raygoza Garay1, Elisabeth L Roberts1, Robab Katani1.
Abstract
Escherichia coli strains are classified based on O-antigens that are components of the lipopolysaccharide (LPS) in the cell envelope. O-antigens are important virulence factors, targets of both the innate and adaptive immune system, and play a role in host-pathogen interactions. Because they are highly immunogenic and display antigenic specificity unique for each strain, O-antigens are the biomarkers for designating O-types. Immunologically, 185 O-serogroups and 11 OX-groups exist for classification. Conventional serotyping for O-typing entails agglutination reactions between the O-antigen and antisera generated against each O-group. The procedure is labor intensive, not always accurate, and exhibits equivocal results. In this report, we present the sequences of 71 O-antigen gene clusters (O-AGC) and a comparison of all 196 O- and OX-groups. Many of the designated O-types, applied for classification over several decades, exhibited similar nucleotide sequences of the O-AGCs and cross-reacted serologically. Some O-AGCs carried insertion sequences and others had only a few nucleotide differences between them. Thus, based on these findings, it is proposed that several of the E. coli O-groups may be merged. Knowledge of the O-AGC sequences facilitates the development of molecular diagnostic platforms that are rapid, accurate, and reliable that can replace conventional serotyping. Additionally, with the scientific knowledge presented, new frontiers in the discovery of biomarkers, understanding the roles of O-antigens in the innate and adaptive immune system and pathogenesis, the development of glycoconjugate vaccines, and other investigations, can be explored.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26824864 PMCID: PMC4732683 DOI: 10.1371/journal.pone.0147434
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Phylogenetic tree for all O-AGCs of E. coli.
The O-AGCs that show 98–99.9% relatedness are highlighted.
Fig 2Comparison of identical O-AGCs.
Comparison of O-AGC of O-groups that are 98–99.9% identical.
| Set # | Computational analysis | Serological cross-reaction | Comparison Status of sequences | Availability |
|---|---|---|---|---|
| 1 | O2/O50 | No | O2 ( | |
| 2 | O13/O129/O135 | Yes | O13 ( | |
| 3 | O17/O44 /O73/ O77/O106 | Yes | O17 ( | |
| 4 | O42/O28ac | Insufficient data | O42 ( | |
| 5 | O46/O134 | No | This study | O46 ( |
| 6 | O62/O68 | O68 cross-reacts with O62 but not vice versa | Liu Y et al. 2015 | O62 ( |
| 7 | O90/O127 | O90 cross-reacts with O127 but not vice versa | O90 ( | |
| 8 | O101 /O162 | O101 cross-react with O162 but not vice versa | O101 ( | |
| 9 | O107/O117 | Yes | O107 ( | |
| 10 | O118/ O151 | No | O118 ( | |
| 11 | O123/O186 | Yes | O123 (n = 45)/O186 (n = 4) | |
| 12 | O124/ O164 | Occasional cross-reaction | O124 ( | |
| 13 | O125ab/O125ac | Insufficient data | This study | O125 ( |
| 14 | OX6/ O168 | Yes | This study | OX6 ( |
| 15 | OX9/O184 | Insufficient data | This study | OX9 ( |
| 16 | OX10/O159 | Yes | This study | OX10 ( |
| 17 | OX19/O11 | No | This study | OX19 ( |
| 18 | OX21/O163 | Yes | This study | OX21 ( |
| 19 | OX38/O128 | Insufficient data | This study | OX38 ( |
| 20 | OX43/O19 | Yes | This study | OX43 ( |
| 21 | O18ab/O18ac | Insufficient Data | O18 (n = 777) |
a, Number of cultures in database of E. coli Reference Center (ECRC) (1967–2015)
Fig 3O153 wzx and wzy genes amplified by PCR using primers from sequences presented in this investigation.
Lanes 1, 7, 13: Molecular weight markers. Lane 2: Positive control for O153 targeting wzx gene, Lane 3: Negative control, Lanes 4,5,6: wzx amplified for three clinical isolates. Lane 9: Positive control for O153 targeting wzy gene. Lane 10: Negative control, Lane 11,12,13: wzy amplified for three clinical isolates.
O-groups that may be potentially merged based on similarities in O-AGC nucleotide sequence and serological cross-reactions.
| Set # | Identity 98–99.9% | Suggested O group |
|---|---|---|
| 1 | O42/O28ac | O42 |
| 2 | O13/O129/O135 | O13 |
| 3 | O107/O117 | O107 |
| 4 | O123/O186 | O123 |
| 5 | O125ab/O125ac | O125 |
| 6 | O18ab/O18ac | O18 |
| 7 | OX6/O168 | O168 |
| 8 | OX10/O159 | O159 |
| 9 | OX21/O163 | O163 |
| 10 | OX38/O128 | O128 |
| 11 | OX43/O19 | O19 |